Guidelines and definitions for research on epithelial-mesenchymal transition
Open accessThe DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Epithelial–mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by ‘the EMT International Association’ (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epithelial-to-mesenchymal transition (EMT) is another potential mechanism of both intrinsic and acquired resistance to KRASG12C inhibitors.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [114]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of canonical EMT transcription factors, including Snai1/2, Zeb1/2, and Twist1, is observed in both contexts77.”
From Cell diversity and plasticity during atrioventricular heart valve EMTs (2023) · cites this paper as [77]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Self-citationNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Self-citationTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Self-citationCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Self-citationEmerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Self-citationBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Self-citationZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Self-citationFischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Research works printed but not linked: 1
- Hay, E. D. in Epithelial–Mesenchymal Interactions: 18th Hahnemann Symposium (eds R. Fleischmajer & Billingham, R. E.) 31–35 (Williams and Wilkins, 1968).
Cited by
Items 301–400 of 1,001
Nasri, A., Foisset, F., Ahmed, E., Lahmar, Z. M., Vachier, I., Jørgensen, C., Assou, S., BOURDIN, A. A., & Vos, J. D. (2021) · Cells · doi:10.3390/cells10123467 · Cited by 46
“Myofibroblasts and fibroblasts could remodel the ECM by releasing matrix metalloproteinases, such as MMP9 [146,147].”
BackgroundInfluentialWang, W., Poe, D., Yang, Y., Hyatt, T., & Xing, J. (2022) · eLife · doi:10.7554/elife.74866 · Cited by 46
“In the EMT field it is under debate whether EMT has a discrete or continuum spectrum of 325 intermediate states (8).”
InfluentialSelf-citationReactivation of embryonic genetic programs in tissue regeneration and disease
Fazilaty, H., & Basler, K. (2023) · Nature Genetics · doi:10.1038/s41588-023-01526-4 · Cited by 44
“The best-studied type of plasticity that is common in development and disease is EMP, which refers to the capacity of cells to undergo EMT as well as the reverse process, mesenchymal–epithelial transition (MET) 34,35 .”
BackgroundInfluentialRenal tubular epithelial cell quality control mechanisms as therapeutic targets in renal fibrosis
Bao, Y., Shan, Q., Lu, K., Yang, Q., Liang, Y., Kuang, H., Wang, L., Hao, M., Peng, M., Zhang, S., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.01.001 · Cited by 45
Winkler, J., Tan, W., Diadhiou, C. M. M., McGinnis, C. S., Abbasi, A. J., Hasnain, S., Durney, S., Atamaniuc, E., Superville, D. A., Awni, L., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci164227 · Cited by 45
“EMT is often defined by the loss or gain of a few canonical markers that are involved in cell adhesion and motility (e.g., VIM , EPCAM , CDH1 , and CDH2 ) and whose expression is regulated by a set of core transcription factors (TFs) (e.g., SNAI1 , SNAI2 , TWIST1 , and ZEB1 ) (6).”
Volumetric compression develops noise-driven single-cell heterogeneity
Zhao, X., Hu, J., Li, Y., & Guo, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110550118 · Cited by 45
Liu, J., Smith, S., & Wang, C. (2022) · ACS Nano · doi:10.1021/acsnano.1c11070 · Cited by 45
Self-citationEpithelial–Mesenchymal Plasticity and Endothelial–Mesenchymal Transition in Cutaneous Wound Healing
Vu, R., Dragan, M., Sun, P., Werner, S., & Dai, X. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041237 · Cited by 45
Hiraki, H. L., Matera, D. L., Wang, W. Y., Prabhu, E. S., Zhang, Z., Midekssa, F. S., Argento, A. E., Buschhaus, J. M., Humphries, B. A., Luker, G. D., et al. (2021) · SSRN Electronic Journal · doi:10.1016/j.actbio.2022.09.043 · Cited by 45
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer
Zong, S., Xu, P.-P., Xu, Y., & Guo, Y. C. (2022) · Journal of Ovarian Research · doi:10.1186/s13048-022-01024-x · Cited by 44
“In the statement, experts emphasized central roles of transcription factors belonging to the ZEB families (Zeb1 and Zeb2) in the execution of EMT in cancer metastasis [44].”
BackgroundZhang, J., van der Zon, G., Ma, J., Mei, H., Cabukusta, B., Agaser, C., Madunić, K., Wuhrer, M., Zhang, T., & ten Dijke, P. (2022) · The EMBO Journal · doi:10.15252/embj.2021110553 · Cited by 44
Mierke, C. T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1130823 · Cited by 44
“ADAMs Protein state (active/inactive) Substrate Functions and possible functions ADAM8 active CD23, c-kit ligand (KL-1), TNFα and amyloid precursor protein (APP) Naus et al. (2006) Proteolytic cleavage of membrane receptors and ECM proteins Fibronectin Zack et al. (2009) Adhesion, angiogenesis, inflammation CD30, TNF-…”
BackgroundInfluentialFerroptosis, autophagy, tumor and immunity
Xie, Y., Zhou, Y., Wang, J., Lijuan, D., Ren, Y., & Liu, F. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19799 · Cited by 44
Zhang, T., Lv, Q., & Jin, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189137 · Cited by 44
Minimal Residual Disease, Metastasis and Immunity
Badia-Ramentol, J., Linares, J., Gómez‐Llonín, A., & Calon, A. (2021) · Biomolecules · doi:10.3390/biom11020130 · Cited by 44
“EMT is defined by the loss of epithelial hallmarks, cell–cell and cell–extracellular matrix adhesion features and gain of a mesenchymal-like transcriptional program [4].”
BackgroundGui, Z., Suo, C., Wang, Z., Zheng, M., Fei, S., Chen, H., Sun, L., Han, Z., Tao, J., Ju, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650424 · Cited by 44
“EMT usually involved three types: (I) embryogenesis, (II) tissue repair and fibrosis, (III) metastasis (8).”
BackgroundLi, Y., He, F., Lin, Q., Liang, F., You, Y., Li, M., Wu, M., Qu, Y., Li, P., Yuan, Y., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01913-3 · Cited by 44
“Six steps constitute the metastasis cascade, namely, dissociation, migration, intravasation, extravasation, reestablishment and eventual formation of secondary tumours in distant organs, during which EMT and mesenchymal–epithelial transition occur [16].”
BackgroundInfluentialCollective metastasis: coordinating the multicellular voyage
Wrenn, E. D., Huang, Y. C., & Cheung, K. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10111-0 · Cited by 44
The role of partial-EMT in the progression of head and neck squamous cell carcinoma
Kisoda, S., Mouri, Y., Kitamura, N., Yamamoto, T., Miyoshi, K., & Kudo, Y. (2022) · Journal of Oral Biosciences · doi:10.1016/j.job.2022.02.004 · Cited by 45
Kim, I., Diamond, M. S., Yuan, S., Kemp, S. B., Kahn, B., Li, Q., Lin, J. H., Li, J., Norgard, R. J., Thomas, S. K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46048-7 · Cited by 43
Self-citationTabei, Y., & Nakajima, Y. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01775-8 · Cited by 43
“Epithelial–mesenchymal transition (EMT) is a cellular process in which fully differentiated epithelial cells lose such characteristics as cell–cell adhesion and apical–basal polarity and acquire mesenchymal properties including motility and invasiveness [1].”
BackgroundHe, B., Hu, Y., Wu, Y., Wang, C., Gao, L., Gong, C., Li, Z., Gao, N., Yang, H., Xiao, Y., et al. (2025) · 癌症:英文版 · doi:10.1002/cac2.70004 · Cited by 43
“The process of tumor metastasis, which involves a series of steps, initially stages with EMT [51, 52] of EMT is strongly interrelated with tumor metastasis and invasion [51, 53].”
New Actors Driving the Epithelial–Mesenchymal Transition in Cancer: The Role of Leptin
Olea‐Flores, M., Juárez-Cruz, J. C., Zuñiga‐Eulogio, M. D., Acosta, E., García-Rodríguez, E., Zacapala-Gómez, A. E., Catalán, M. A. M., Ortiz‐Ortiz, J., Ortuño‐Pineda, C., & Navarro‐Tito, N. (2020) · Biomolecules · doi:10.3390/biom10121676 · Cited by 43
“Several of the mediators of cell junctions have been characterized as classic epithelial markers, such as E-cadherin in the adherent junctions; claudins, occludins, and ZO proteins in tight junctions; and the loss of desmoplakin in desmosomes [46].”
BackgroundLncRNA influence sequential steps of hepatocellular carcinoma metastasis
Lv, E., Sheng, J., Yu, C., Rao, D., & Huang, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111224 · Cited by 43
The role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis
Peng, P., Hsu, K., Lai, J. C., & Wu, K. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.03.005 · Cited by 43
Green, B. J., Marazzini, M., Hershey, B. J., Fardin, A., Li, Q., Wang, Z., Giangreco, G., Pisati, F., Marchesi, S., Disanza, A., et al. (2022) · Small · doi:10.1002/smll.202106097 · Cited by 43
Walters, E. H., Shukla, S. D., Mahmood, M. Q., & Ward, C. (2021) · European Respiratory Review · doi:10.1183/16000617.0364-2020 · Cited by 42
Ion Channels in Gliomas—From Molecular Basis to Treatment
Elias, A. F., Lin, B. C., & Piggott, B. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032530 · Cited by 44
“For instance, it was found that cells became softer by downregulating keratin following epithelial–mesenchymal transformation [166,167].”
BackgroundMutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR
Schuhwerk, H., & Brabletz, T. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.009 · Cited by 42
Self-citationKlabukov, I., Smirnova, A., Yakimova, A. O., Kabakov, A. E., Atiakshin, D., Petrenko, D. А., Shestakova, V. A., Sulina, Y. Y., Yatsenko, E., Stepanenko, V. N., et al. (2024) · Journal of Molecular Pathology · doi:10.3390/jmp5040029 · Cited by 42
“This intermediate state is increasingly recognized as important in cancer metastasis and tissue regeneration, allowing cells to maintain some degree of cell–cell adhesion while gaining motility [119].”
Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
Dong, B., Qiu, Z., & Wu, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.596239 · Cited by 42
“Such cellular conversions and the resultant heterogeneity are believed to equip cells with pliability to cope with different developmental and pathological occasions (Yang et al., 2020).”
BackgroundHan, L., Wang, S., Wei, C., Fang, Y., Huang, S., Yin, T., Xiong, B., & Yang, C. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.13 · Cited by 44
Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
Li, X., Chen, L., Peng, X., & Zhan, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.911410 · Cited by 43
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease
Srivastava, S. P., Zhou, H., Shenoi, R., Morris, M., Lainez, B., Goedeke, L., Rajendran, B. K., Setia, O., Aryal, B. K., Kanasaki, K., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn6068 · Cited by 41
In vivo Neural Crest Cell Migration Is Controlled by “Mixotaxis”
Barriga, E. H., & Théveneau, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.586432 · Cited by 41
Li, T., Fu, X., Liu, B., Wang, X., Li, J., Zhu, P., Niu, X., Bai, J., Liu, Y., Lu, X., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115044 · Cited by 41
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Li, X.-M., Zhao, Z., Xiao, Y., Xia, Q., Zhou, P., Wang, S., Wu, H., & Hu, J. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00394-2 · Cited by 41
Xie, L., Wang, J., Song, L., Jiang, T., & Yan, F. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01398-4 · Cited by 41
Ferroptosis as a promising therapeutic strategy for melanoma
Ta, N., Jiang, X., Zhang, Y., & Wang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1252567 · Cited by 41
Pan, L., Hao, W., Xue, Y., Wang, K., Zheng, X., Luo, J., Ba, X., Xiang, Y., Qin, X., Bergwik, J., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1241 · Cited by 40
“Apart from using protein markers to define the EMT program, cell phenotypic plasticity is key to characterize this process (41).”
MethodProline is increased in allergic asthma and promotes airway remodeling
Xu, T., Wu, Z., Yuan, Q., Zhang, X., Liu, Y., Wu, C., Song, M., Wu, J., Jiang, J., Wang, Z., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167395 · Cited by 40
Tumor dormancy: EMT beyond invasion and metastasis
Aouad, P., Quinn, H. M., Berger, A., & Brisken, C. (2023) · genesis · doi:10.1002/dvg.23552 · Cited by 40
“…into three distinct types based on its biological context: physiologically during embryonic development (type I), in response to tissue injury (type II), and pathologically during cancer invasion and metastasis (type III; Brabletz et al., 2018; Kalluri & Weinberg, 2009; Yang et al., 2020).”
BackgroundExploring the Role of the Gut and Intratumoral Microbiomes in Tumor Progression and Metastasis
Ševčíková, A., Mladosievičová, B., Mego, M., & Čierniková, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417199 · Cited by 40
Cruz, M. C. P. D., & Medina, P. M. B. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.07.001 · Cited by 40
NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression
Han, H., Zhang, C., Shi, W., Wang, J., Zhao, W., Du, Y., Zhao, Z., Wang, Y., Lin, M., Qin, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202404083 · Cited by 40
Genes involved in the epithelial-mesenchymal transition in oral cancer: A systematic review
Vallina, C., López‐Pintor, R. M., González‐Serrano, J., de Vicente, J. C., Hernández, G., & Lorz, C. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105310 · Cited by 40
Hassan, S., Blick, T., Thompson, E. W., & Williams, E. D. (2021) · Cancers · doi:10.3390/cancers13112750 · Cited by 40
“Non-EMT-associated roles have been reported for factors such as Snail-1 [21], and it is noteworthy that Snail-1 can promote tumour progression without suppression of E-cadherin.”
BackgroundSelf-citationParsing β-catenin’s cell adhesion and Wnt signaling functions in malignant mammary tumor progression
Buechel, D., Sugiyama, N., Rubinstein, N., Saxena, M. T., Kalathur, R. K. R., Lüönd, F., Vafaizadeh, V., Valenta, T., Hausmann, G., Cantù, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020227118 · Cited by 40
Self-citationYan, Y., Cai, J., Huang, Z., Cao, X., Tang, P., Wang, Z., Zhang, F., Xia, S., & Shen, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.712230 · Cited by 40
Bidirectional Mechanical Response Between Cells and Their Microenvironment
Mierke, C. T. (2021) · Frontiers in Physics · doi:10.3389/fphy.2021.749830 · Cited by 40
“Collectively, these dynamic events have been more widely characterized as socalled epithelial-mesenchymal plasticity [352].”
BackgroundKieu, T., Pierre, L., Dérangère, V., Perrey, S., Truntzer, C., Jalil, A., Causse, S., Groetz, E., Dumont, A., Guyard, L., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05209-6 · Cited by 40
“Downregulation of Elovl5 increases the invasiveness and expression of EMT markers The metastatic process at the cellular level is associated with the acquisition of invasive properties and a mesenchymal phenotype [12].”
BackgroundZhang, K., Dong, Y., Li, M., Zhang, W., Ding, Y., Wang, X., Chen, D., Liu, T., Wang, B., Cao, H., et al. (2023) · Cancer Science · doi:10.1111/cas.15839 · Cited by 40
Zhang, K., Lin, L., Zhu, Y., Zhang, N., Zhou, M., & Li, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.894981 · Cited by 39
The transcriptional landscape of glycosylation-related genes in cancer
Rodríguez, E., Lindijer, D., van Vliet, S. J., García-Vallejo, J. J., & van Kooyk, Y. (2024) · iScience · doi:10.1016/j.isci.2024.109037 · Cited by 39
EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer
Chen, Y., Zhu, H., Luo, Y., Tong, S., & Liu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116624 · Cited by 39
Kim, S.-K., Jang, S. D., Kim, H., Chung, S. H., Park, J. K., & Kuh, H. (2020) · Cancers · doi:10.3390/cancers12051305 · Cited by 40
“Recent evidence indicates, however, that EMT induces a broad range of intermediate epithelial and mesenchymal stages such as partial EMT states, and that it contributes to phenotypic plasticity of cancer cells in invasion and metastasis, especially in collective cell migration [63,64].”
BackgroundLeptin promotes bone metastasis of breast cancer by activating the SDF-1/CXCR4 axis
Duan, L., Lu, Y., Xie, W., Li, N., Jia, Y., Tan, A., & Liu, Y. (2020) · Aging · doi:10.18632/aging.103599 · Cited by 39
“In EMT, immotile epithelial cells acquire mesenchymal characteristics and lose cell polarity and cell-to-cell adhesion, thus enabling increased migration and invasiveness [27].”
BackgroundCell shape changes during larval body plan development in Clytia hemisphaerica
Kraus, Y. A., Chevalier, S., & Houliston, E. (2020) · Developmental Biology · doi:10.1016/j.ydbio.2020.09.013 · Cited by 39
Born to Run? Diverse Modes of Epithelial Migration
Lu, P., & Lu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.704939 · Cited by 39
Wang, Z., Hulsurkar, M. M., Zhuo, L., Xu, J., Yang, H., Naderinezhad, S., Wang, L., Zhang, G., Ai, N., Li, L., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.09.005 · Cited by 39
Misztal, C. I., Green, C., Mei, C., Bhatia, R. G., Torres, J. M. V., Kamrava, B., Moon, S. Y., Nicolli, E. A., Weed, D. T., Sargi, Z., et al. (2021) · Cancers · doi:10.3390/cancers13236011 · Cited by 39
Han, Y., VILLARREAL-PONCE, A. P., Gutierrez, G., Nguyen, Q., Sun, P., Wu, T. H., Sui, B., Berx, G., Brabletz, T., Kessenbrock, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110240 · Cited by 39
“Epithelial-to-mesenchymal transition (EMT) describes a heterogeneous spectrum of cellular plasticity, where epithelial cells lose or attenuate their epithelial traits and gain partial or complete mesenchymal characteristics (Haensel and Dai, 2018; Nieto et al., 2016; Pastushenko and Blanpain, 2019; Sha et al., 2019; T…”
BackgroundSelf-citationBiophysics Role and Biomimetic Culture Systems of ECM Stiffness in Cancer EMT
Tian, H., Shi, H., Yu, J., Ge, S., & Ruan, J. (2022) · Global Challenges · doi:10.1002/gch2.202100094 · Cited by 39
Ramadhiani, R., Ikeda, K., Hirata, K., & Emoto, N. (2021) · Institutional Repositories DataBase (IRDB) · doi:10.24546/81013008 · Cited by 39
Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms
Ameri, A., Ahmed, H. M., Pecho, R. D. C., Arabnozari, H., Sarabadani, H., Esbati, R., Mirabdali, S., & Yazdani, O. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03105-3 · Cited by 39
“Through a process known as epithelial-mesenchymal transition (EMT), epithelial cells lose their epithelial characteristics and obtain mesenchymal cells phenotype [14].”
BackgroundWang, L., Fu, H., Song, L., Wu, Z., Yu, J., Guo, Q., Chen, C., Yang, X., Zhang, J., Wang, Q., et al. (2022) · Small · doi:10.1002/smll.202204133 · Cited by 38
Okuyama, K., Suzuki, K., & Yanamoto, S. (2023) · Cancers · doi:10.3390/cancers15041111 · Cited by 38
“recommended the use of the term “epithelial–mesenchymal plasticity” (EMP) to describe the ability of cells to adopt mixed E/M features and to interconvert intermediate E/M phenotypic states arrayed along an epithelial–mesenchymal spectrum [55].”
BackgroundYao, L., Li, J., Jiang, B., Zhang, Z., Li, X., Ouyang, X., Xiao, Y., Liu, G., Wang, Z., & Zhang, G. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05785-1 · Cited by 38
“[17, 18] EMT is marked by multiple proteins including E-Cadherin, Claudins, N-Cadherin, etc, in which E-Cadherin is an important epithelial marker that mediates suppressive effects in tumor metastasis.”
BackgroundInfluentialHuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells
Morillo-Bernal, J., Pizarro-García, P., Moreno‐Bueno, G., Cano, A., Mazón, M. J., Eraso, P., & Portillo, F. (2024) · Cancers · doi:10.3390/cancers16020384 · Cited by 38
Self-citationPawlicka, M., Gumbarewicz, E., Błaszczak, E., & Stepulak, A. (2024) · Cancers · doi:10.3390/cancers16071354 · Cited by 38
“MET is also associated with cancer, particularly metastasis, where mesenchymal cells revert to epithelial ones to regain proliferating abilities at secondary sites [30].”
BackgroundWang, Z., Elbanna, Y. A., Godet, I., Gan, S., Peters, L., Lampe, G. D., Chen, Y., Xavier, J. B., Huse, M., & Massagué, J. (2026) · Nature Cancer · doi:10.1038/s43018-025-01094-y · Cited by 38
Self-citationHuman Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity
Strietz, J., Stepputtis, S. S., Follo, M., Bronsert, P., Stickeler, E., & Maurer, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041808 · Cited by 38
“Nevertheless, all BCSCs co-expressed mesenchymal and epithelial markers simultaneously, suggesting an EMP state for triple-negative BCSCs. Similar expression of the EMT-related genes could be observed at the mRNA level when the cells were cultured in a 3D cell culture environment using 50% Matrigel (Figure S12).”
BackgroundInfluentialRuh, M., Stemmler, M. P., Frisch, I., Fuchs, K., van Roey, R., Kleemann, J., Roas, M., Schuhwerk, H., Eccles, R. L., Agaimy, A., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5659 · Cited by 38
“ZEB1, SNAI1, and TWIST1 immunohistochemistry (anti-ZEB1, SigmaPrestige, HPA027524, 1:1000; anti-SNAIL, Cell Signaling Technology, 3879, 1:50; anti-TWIST1, Abcam, Cambridge, UK; ab50581, 1:100) was performed as previously described [25].”
BackgroundResultInfluentialSelf-citationInteractions and Feedbacks in E-Cadherin Transcriptional Regulation
Moreno, M. R., Stempor, P., & Bulgakova, N. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701175 · Cited by 38
The Role of Defective Epithelial Barriers in Allergic Lung Disease and Asthma Development
Noureddine, N., Chalubinski, M., & Wawrzyniak, P. (2022) · Journal of Asthma and Allergy · doi:10.2147/jaa.s324080 · Cited by 38
“The epithelial cells lose their cell polarity and cell–cell adhesion, then display fibroblast-like morphology and cytoarchitecture, and gain migratory and invasive properties.(62,63) The Wnt/β-catenin pathway was shown to be involved in the remodeling process of fibrosis and allergic inflammation in a genetically modi…”
BackgroundNew Perspectives on the Role of Integrin-Linked Kinase (ILK) Signaling in Cancer Metastasis
McDonald, P. C., & Dedhar, S. (2022) · Cancers · doi:10.3390/cancers14133209 · Cited by 38
“Following infiltration and colonization of distant sites, cells may undergo the reverse process, mesenchymal epithelial transition (MET) to enable proliferation and growth [2,46].”
BackgroundInfluentialSelf-citationSun, X., Malandraki-Miller, S., Kennedy, T. L., Bassat, E., Klaourakis, K., Zhao, J., Gamen, E., Vieira, J. M., Tzahor, E., & Riley, P. R. (2021) · Development · doi:10.1242/dev.197525 · Cited by 38
Hypoxia signaling and metastatic progression
Schito, L., & Rey-Keim, S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.001 · Cited by 37
Bruneel, K., Verstappe, J., Vandamme, N., & Berx, G. (2020) · Cancers · doi:10.3390/cancers12082248 · Cited by 37
“Indeed, EMT TFs influence not only the proliferative and invasive capacities of carcinoma cells but are also important in other EMP-related processes, including cell differentiation, cell state transition, cancer stem cell formation, survival and senescence, therapy resistance, immune evasion and shaping of the micro-…”
BackgroundInfluentialSelf-citationSha, Y., Wang, S., Bocci, F., Zhou, P., & Nie, Q. H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.604585 · Cited by 37
Meng, X.-Y., Zhang, H., Ren, Y., Wang, K., Chen, J., Su, R., Jiang, J., Wang, P., & Ma, Q. (2021) · American Journal of Cancer Research · Cited by 37
Liu, Q.-L., Luo, M., Huang, C., Chen, H., & Zhou, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.657546 · Cited by 37
“Indeed, it was proposed by recent studies using subtle mathematical models that blocking the feedback loops integrated in the EMP network is likely to impair the metastatic potential of cancer cells (90).”
BackgroundInfluentialDardare, J., Witz, A., Merlin, J., Bochnakian, A., Toussaint, P., Gilson, P., & Harlé, A. (2021) · Pharmaceuticals · doi:10.3390/ph14080740 · Cited by 37
“During EMT, epithelial cells undergo changes in gene expression through multiple molecular processes leading to the repression of these epithelial characteristics and gain of mesenchymal features allowing cells migrative and invasive properties [13].”
BackgroundWu, Y., Liang, X., Ni, J., Zhao, R., Shao, S., Si, L., Han, W., & Yu, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.681240 · Cited by 37
“Gene set enrichment analysis (GSEA) was performed using the “clusterProfiler” package (Subramanian et al., 2005; Yu et al., 2012).”
MethodHierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching
Lüönd, F., Pirkl, M., Hisano, M., Prestigiacomo, V., Kalathur, R. K. R., Beerenwinkel, N., & Christofori, G. (2021) · Life Science Alliance · doi:10.26508/lsa.202101010 · Cited by 37
“Of note, EMT is not a binary switch but covers a continuum of intermediate states under the control of distinct and hierarchical regulatory networks (Huang et al, 2013; Zhang et al, 2014; Jolly et al, 2016; Pastushenko et al, 2018; Meyer-Schaller et al, 2019; Yang et al, 2020).”
Self-citationMa, Y., Liang, Q., Wang, F., Yan, K., Sun, M., Lin, L., Li, T., Duan, J., & Sun, Z. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113303 · Cited by 37
Jain, P., Corbo, S., Mohammad, K., Sahoo, S., Ranganathan, S., George, J. T., Levine, H., Taube, J. H., Toneff, M. J., & Jolly, M. K. (2023) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0627 · Cited by 37
Self-citationHost Cell Targets for Unconventional Antivirals against RNA Viruses
Roa-Linares, V. C., Escudero-Flórez, M., Vicente‐Manzanares, M., & Gallego-Gómez, J. C. (2023) · Viruses · doi:10.3390/v15030776 · Cited by 37
“It is an epigenetic program characterized by a progressive loss of epithelial polarity, the acquisition of individual cellular motility, and an invasive capacity [61].”
BackgroundTMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer
Kim, S. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00975-5 · Cited by 37
Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease
Du, J., Shui, H., Chen, R., Dong, Y., Xiao, C., Hu, Y., & Wong, N.-K. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46080475 · Cited by 37
“Within models of unilateral ureteral ligation (UUO) and folic acid (FA) stimulation, NEU1 knockout was effective in inhibiting epithelial/mesenchymal transition [121], inflammatory cytokine production, and collagen deposition, thus alleviating renal fibrosis and renal injury.”
BackgroundEpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer
Mal, A., Bukhari, A. B., Singh, R. K., Kapoor, A., Barai, A., Deshpande, I., Wadasadawala, T., Ray, P., Sen, S., & De, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.597673 · Cited by 36
“But, most of times cells are not in binary state, either being completely mesenchymal or epithelial (Kroger et al., 2019; Yang et al., 2020).”
BackgroundEiró, N., Fraile, M., Fernández-Francos, S., Sánchez, R., Costa, L. A., & Vizoso, F. J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00620-6 · Cited by 36
Yang, C., Cao, F., Huang, S., & Zheng, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717505 · Cited by 36
“It is well known that EMT, an important hallmark of advanced cancer, is a key step for cancer cells to acquire metastasis potential (41).”
BackgroundTopological isolation of developmental regulators in mammalian genomes
Wu, H., Landshammer, A., Stamenova, E. K., Bolondi, A., Kretzmer, H., Meissner, A., & Michor, F. (2021) · Nature Communications · doi:10.1038/s41467-021-24951-7 · Cited by 36
Racu, M.-L., Lebrun, L., Schiavo, A. A., Campenhout, C. V., Clercq, S. D., Absil, L., Minguijón, E., Maris, C., Decaestecker, C., Salmon, I. J., et al. (2022) · Cancers · doi:10.3390/cancers14040973 · Cited by 38
“Finally, we hypothesize that the disagreements concerning the biological function of SMAD4 in PDAC might be due to its implication in the process of EMP.”
BackgroundInfluentialThe overall process of metastasis: From initiation to a new tumor
Fan, T., Kuang, G., Long, R., Han, Y., & Wang, J. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188750 · Cited by 36
Ezrin gone rogue in cancer progression and metastasis: An enticing therapeutic target
Barik, G. K., Sahay, O., Paul, D., & Santra, M. K. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188753 · Cited by 36
Combined inhibition of ACLY and CDK4/6 reduces cancer cell growth and invasion
Velez, B. C., Petrella, C., DiSalvo, K. H., Cheng, K., Kravtsov, R. L., Krasniqi, D., & Krucher, N. A. (2022) · Oncology Reports · doi:10.3892/or.2022.8469 · Cited by 36
Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy
Datlibagi, A., Zein-El-Din, A., Frohly, M., Willermain, F., Delporte, C., & Motulsky, E. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054509 · Cited by 36
“Similarly, endothelial cells can also undergo a process called endothelial–mesenchymal transition, as seen in embryogenesis, cardiac fibrosis, and fibrovascular membranes found in PDR and nAMD [5,15,16,20].”
BackgroundMonoterpenoids: An upcoming class of therapeutic agents for modulating cancer metastasis
Mathur, A., Meena, A., & Luqman, S. (2023) · Phytotherapy Research · doi:10.1002/ptr.8081 · Cited by 36
“The stromal signals that trigger EMTs include TGF-β , WNT, and nuclear factor kappa B (NF-κ B) activators (Nieto et al., 2016; Pastushenko et al., 2018; Yang et al., 2020).”
Background
Metadata
- Authors
- Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., Dedhar, S., Derynck, R., Ford, H. L., Fuxe, J., García de Herreros, A., Goodall, G. J., Hadjantonakis, A.-K., Huang, R. Y. J., Kalcheim, C., Kalluri, R., Kang, Y., Khew-Goodall, Y., Levine, H., Liu, J., Longmore, G. D., Mani, S. A., Massagué, J., Mayor, R., McClay, D., Mostov, K. E., Newgreen, D. F., Nieto, M. A., Puisieux, A., Runyan, R., Savagner, P., Stanger, B., Stemmler, M. P., Takahashi, Y., Takeichi, M., Theveneau, E., Thiery, J. P., Thompson, E. W., Weinberg, R. A., Williams, E. D., Xing, J., Zhou, B. P., Sheng, G., & On behalf of the EMT International Association (TEMTIA)
- Affiliations
- University of California San Diego (US)
- University of Arizona (US)
- Ghent University (BE)
- Université Libre de Bruxelles (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Sheffield (GB)
- Instituto de Investigaciones Biomédicas Sols-Morreale (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- University of Basel (CH)
- University of British Columbia (CA)
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Karolinska University Hospital (SE)
- South Australia Pathology (AU)
- Memorial Sloan Kettering Cancer Center (US)
- National Taiwan University (TW)
- Hebrew University of Jerusalem (IL)
- The University of Texas MD Anderson Cancer Center (US)
- Princeton University (US)
- Northeastern University (US)
- Washington University in St. Louis (US)
- University College London (GB)
- Duke University (US)
- Royal Children's Hospital (AU)
- Instituto de Neurociencias (ES)
- Lyon 1 Université (FR)
- Inserm (FR)
- University of Pennsylvania (US)
- Kyoto University (JP)
- RIKEN Center for Biosystems Dynamics Research (JP)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN)
- Translational Research Institute (AU)
- Whitehead Institute for Biomedical Research (US)
- Queensland University of Technology (AU)
- University of Pittsburgh (US)
- University of Kentucky (US)
- International Research Center for Medical Sciences, Kumamoto University (JP)
- Corresponding author
- Yang, Jing
- Sheng, Guojun
- ORCID
- Yang, Jing
- Antin, Parker
- Berx, Geert
- Blanpain, Cédric
- Brabletz, Thomas
- Campbell, Kyra
- Casanova, Jordi
- Christofori, Gerhard
- Dedhar, Shoukat
- Derynck, Rik
- Ford, Heide L.
- Fuxe, Jonas
- Goodall, Gregory J.
- Hadjantonakis, Anna-Katerina
- Huang, Ruby Y. J.
- Kalcheim, Chaya
- Kalluri, Raghu
- Kang, Yibin
- Levine, Herbert
- Liu, Jinsong
- Longmore, Gregory D.
- Mani, Sendurai A.
- Massagué, Joan
- Mayor, Roberto
- McClay, David
- Mostov, Keith E.
- Newgreen, Donald F.
- Nieto, M. Angela
- Puisieux, Alain
- Runyan, Raymond
- Savagner, Pierre
- Stanger, Ben
- Stemmler, Marc P.
- Takahashi, Yoshiko
- Takeichi, Masatoshi
- Theveneau, Eric
- Thiery, Jean Paul
- Thompson, Erik W.
- Weinberg, Robert A.
- Williams, Elizabeth D.
- Xing, Jianhua
- Zhou, Binhua P.
- Sheng, Guojun
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2020-04-16
- Volume
- 21
- Issue
- 6
- Pages
- 341-352
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC7250738
- OpenAlex
- W3016840787
- Cited by
- 2,226
- References
- 139
- Citations by year
- 2026: 249 · 2025: 382 · 2024: 403 · 2023: 396 · 2022: 386 · 2021: 313 · 2020: 88
- FWCI
- 32.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-10-15)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Biblos-e Archivo (Universidad Autónoma de Madrid) (submittedVersion, public-domain)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Hispana (submittedVersion)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (204615/Z/16/Z)
- Biotechnology and Biological Sciences Research Council (BB/R00627X/1, BB/T013044/1)
- Japan Society for the Promotion of Science (19H04775, 20K21425, 18H02452, 20K20520, 16KT0071)
- National Cancer Institute (R01CA223758, R37CA232209, P30CA023100, P30CA016672)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119232)
- National Institute of Environmental Health Sciences (P30ES006694)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P41HD088362)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- epithelial-mesenchymal transition, nomenclature, research guidelines, cell migration, cell invasion, transcription factors, cancer, developmental processes
- MeSH terms
- Cell Plasticity, Animals, Cell Movement, Humans, Neoplasms, Terminology as Topic, Developmental Biology, Consensus, Biomedical Research, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.